Given that PDE5 inhibitors are commonly used in patients with ED and PH, our findings may have significant clinical implications in alerting physicians of putative adverse effect of PDE5 inhibitors

Given that PDE5 inhibitors are commonly used in patients with ED and PH, our findings may have significant clinical implications in alerting physicians of putative adverse effect of PDE5 inhibitors. == Materials and Methods == == Chemicals and antibodies == Tadalafil and vardenafil were obtained from Selleckchem (Houston, TX, USA). KT5823, 8-Br(Bromo)-cGMP, Alizarin Red S, and SB216763 were from Sigma (St Louis, MO, USA). marrow-derived stromal cells, resulting in the reduction of bone mass in wild-type adult C57B/6 mice, significantly attenuated secreted Frizzled-related protein-1 (SFRP1) deletion-induced activation of canonical Wnt signaling and excessive bone growth in adult SFRP1/mice. Together, these results uncover a hitherto uncharacterized role of PDE5/cGMP/PKG BMS-806 (BMS 378806) signaling in bone homeostasis and provide the evidence that long-term treatment with PDE5 inhibitors at a high dosage may potentially cause bone catabolism. In the canonical Wnt (Wnt/-catenin (-cat)) signaling cascade, Wnt binds to Frizzled (Frz) receptors and the low-density lipoprotein receptor-related protein (LRP) 5 or 6, thereby activating dishevelled, suppressing the glycogen synthase kinase 3(GSK3) activity and inhibiting Rabbit Polyclonal to RPL39 phosphorylation of-cat at Thr41, Ser37, and Ser33 sites. The stabilized cytosolic-cat enters the nucleus and consequently activates its downstream target genes via lymphoid enhancer-binding factor-1 (Lef-1) and T-cell factors.1,2This signaling is fine-tuned in part via a negative feedback mechanism involving secreted and transmembrane Wnt inhibitors and activators, secreted Frz-related proteins (SFRPs), and Dickkopf-1 (Dkk1).3,4 Canonical Wnt signaling is critical not only to bone development in embryogenesis but also to the maintenance of bone mass during BMS-806 (BMS 378806) adult life.5The initial evidence came from the discoveries that in humans loss- or gain-of-function mutations in LRP5 were linked with the osteoporosis-pseudoglioma syndrome and a high-bone-density syndrome, respectively.6,7,8Subsequent studies in mice showed that Wnt signaling might promote ossification by inducing the differentiation of bone-forming osteoblasts, suppressing the development of bone-resorbing osteoclasts, and driving the differentiation of multi-potent stem cells toward an osteoblast cell fate.9 Non-canonical Wnt signaling is-cat independent and consists of two main pathways: the Rho small GTPases-mediated planar cell polarity pathway and the Wnt/Ca2+pathway,10involved in various aspects of cell fate differentiation and cell movement. Non-canonical Wnt signaling has profound effects on tissue morphogenesis in a variety of vertebrate species.10The potential role for non-canonical Wnt signaling in bone formation has been investigated recently in limited studies, which have shown that the non-canonical Wnt-Gq/11-PKC pathway operates in mammalian osteoprogenitors to promote osteoblast development, and that Wnt16 exhibits a stimulatory effect on bone metabolism.11,12,13Nevertheless, the molecular BMS-806 (BMS 378806) events in the non-canonical Wnt signaling regulation of bone development and homeostasis have yet to be further elucidated. Phosphodiesterases (PDEs) are a large family of enzymes that cleave cyclic nucleotides. To date, 11 PDE subtypes have been identified, among which PDE5 has been most extensively studied. PDE5, cyclic guanosine monophosphate (cGMP), and cGMP-dependent protein kinase (PKG) are among the major components of the non-canonical Wnt signaling pathway and are involved in the regulation of intracellular Ca2+concentration.14,15It is now well established that PDE5 degrades 3′-5- cGMP and its inhibition leads to an increase in intracellular cGMP levels and activation of protein kinase G (PKG), resulting in a decrease in Ca2+influx and consequent relaxation of smooth muscles, which produces the therapeutic effects in clinical erectile dysfunction (ED) and pulmonary hypertension (PH).14Currently, little is known regarding the involvement of PDE5 in Wnt signaling regulation of bone formation and homeostasis. The objective of this study was to determine the effect of PDE5 inhibition on canonical Wnt signaling and bone mass. == Results == == Involvement of PDE5 and PKG in canonical Wnt signaling == To examine the possibility of PDE5 and PKG in canonical Wnt signaling, we determined the effects of PDE5 and PKG inhibitors, and PDE5- and PKG-specific siRNAs on Lef1 reporter activity in 293 T cells. The two PDE5 inhibitors (i.e., tadalafil and vardenafil) used inhibited the Lef1-luciferase activity in a dose-dependent manner; at 10M, tadalafil and vardenafil decreased the reporter activity by 58 and 30%, respectively, in the presence of control L cell-conditioned medium (L), and by 42 and 60%, respectively, in the presence of Wnt3a-expressing cell-conditioned medium (Wnt3a) (Figure 1aandSupplementary Figure 1a). In contrast, KT5823, a potent inhibitor of PKG, dose dependently induced the Lef1-luciferase activity in 293 T cells; at 5M, it increased the reporter activity by 2.4- and 1.5-fold, respectively, in the presence of control BMS-806 (BMS 378806) L cell-conditioned medium and Wnt3a-expressing cell-conditioned medium (Figure 1b). Neither tadalafil nor KT5823 at the indicated concentrations affected the apoptosis of either 293 T.